{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:01:54Z","timestamp":1790139714257,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Low 25-Hydroxy-vitamin-D; \u201c25(OH)-D3\u201d serum and vitamin D receptor (VDR) levels were recently correlated to advanced fibrosis. However, VDR mechanism in liver fibrosis modulations is not well understood. In this study, we aimed to evaluate changes in liver NK cells cytotoxicity due to modulations in VDR in CCl<jats:sub>4<\/jats:sub> fibrosis model following 25(OH) D3 injections.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Carbon-tetrachloride (CCl<jats:sub>4<\/jats:sub>) hepatic-fibrosis was induced in BALB\/c mice for 1 and 4\u2009weeks as an acute and chronic fibrosis model, respectively. Along 1th to 4th weeks, vitamin D were i.p injected\/2x week. Liver were assessed histologically and for proteins quantification for VDR and \u03b1SMA expressions. In vitro, potential killing of NK cells were evaluated following co-culture with primary-hepatic-stellate-cells (pHSCs) obtained from BALB\/c WT-mice.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Systemic inflammation and hepatic-fibrosis increased along 4\u2009weeks of CCl<jats:sub>4<\/jats:sub> as indicated by serum ALT and \u03b1SMA expressions (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.02) as well as histological assessments, respectively. These results were associated with increased NK1.1 activations and hypercalcemia. While vitamin D administrations delayed fibrosis of early stages, vitamin D worsen hepatic-fibrosis of late stages of CCl<jats:sub>4<\/jats:sub>. In week 4, no further activations of NK cells were seen following vitamin D injections and were associated with down-expressions of VDR (1.7 Fold, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.004) indicating the inability of vitamin D to ameliorate hepatic fibrosis. In vitro, NK cells from the chronic model of CCl<jats:sub>4<\/jats:sub> did not affect pHSCs killing and fail to reduce fibrosis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Vitamin D alleviate liver NK cytotoxicity in acute but not in chronic fibrosis model due to modulations in vitamin D receptor and calcium. Hypercalcemia associated with late fibrosis may inhibited VDR levels, however, may not explain the profibrogenic effects of vitamin D.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12876-020-01248-5","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T20:02:12Z","timestamp":1586548932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["25(OH) D3 alleviate liver NK cytotoxicity in acute but not in chronic fibrosis model of BALB\/c mice due to modulations in vitamin D receptor"],"prefix":"10.1186","volume":"20","author":[{"given":"Ahmad","family":"Salhab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yinying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifaat","family":"Safadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,10]]},"reference":[{"key":"1248_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1210\/edrv-3-4-331","volume":"3","author":"AW Norman","year":"1982","unstructured":"Norman AW, Roth J, Orci L. The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev. 1982;3:331\u201366.","journal-title":"Endocr Rev"},{"key":"1248_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-381978-9.10001-0","volume-title":"Vitamin D","author":"HF Deluca","year":"2011","unstructured":"Deluca HF. Historical overview of Vitamin D. In: Feldman D, Pike JW, Adams JS, editors. Vitamin D, vol. Vol 1. 3rd ed. Boston: Elsevier; 2011. p. 3\u201312.","edition":"3"},{"key":"1248_CR3","doi-asserted-by":"publisher","first-page":"re4","DOI":"10.1126\/scisignal.275re4","volume":"2","author":"MT Mizwicki","year":"2009","unstructured":"Mizwicki MT, Norman AW. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Sci Signal. 2009;2:re4.","journal-title":"Sci Signal"},{"key":"1248_CR4","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1111\/j.1753-4887.2008.00105.x","volume":"66","author":"HF DeLuca","year":"2008","unstructured":"DeLuca HF. Evolution of our understanding of vitamin D. Nutr Rev. 2008;66:S73\u201387.","journal-title":"Nutr Rev"},{"key":"1248_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00223-012-9619-0","volume":"92","author":"MR Haussler","year":"2013","unstructured":"Haussler MR, Whitfield GK, Kaneko I, et al. Molecular mechanisms of vitamin D action. Calcif Tissue Int. 2013;92:77\u201398.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1248_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1185\/030079907X253519","volume":"24","author":"BA Ingraham","year":"2008","unstructured":"Ingraham BA, Bragdon B, Nohe A. Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin. 2008;24(1):139\u201349 Review.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"1248_CR7","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/jvh.13076","volume":"26","author":"D Palazzo","year":"2019","unstructured":"Palazzo D, Biliotti E, Esvan R, Volpicelli L, Franchi C, Fontanelli Sulekova L, et al. Vitamin D deficiency and health-related quality of life in chronic hepatitis C. J Viral Hepat. 2019;26(6):774\u20137.","journal-title":"J Viral Hepat"},{"issue":"4","key":"1248_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.14740\/gr1072w","volume":"11","author":"V Gayam","year":"2018","unstructured":"Gayam V, Mandal AK, Khalid M, Mukhtar O, Gill A, Garlapati P, et al. Association Between Vitamin D Levels and Treatment Response to Direct-Acting Antivirals in Chronic Hepatitis C: A Real-World Study. Gastroenterology Res. 2018;11(4):309\u201316.","journal-title":"Gastroenterology Res"},{"issue":"7","key":"1248_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/MEG.0000000000001134","volume":"30","author":"CN Jin","year":"2018","unstructured":"Jin CN, Chen JD, Sheng JF. Vitamin D deficiency in hepatitis C virus infection: what is old? what is new? Eur J Gastroenterol Hepatol. 2018;30(7):741\u20136.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1248_CR10","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.biopha.2018.10.140","volume":"109","author":"W Udomsinprasert","year":"2019","unstructured":"Udomsinprasert W, Jittikoon J. Vitamin D and liver fibrosis: Molecular mechanisms and clinical studies. Biomed Pharmacother. 2019;109:1351\u201360 Review.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1248_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.4238\/2015.February.6.1","volume":"14","author":"F Fang","year":"2015","unstructured":"Fang F, Wang J, Pan J, Su GH, Xu LX, Li G. Relationship between vitamin D (1,25-dihydroxyvitamin D3) receptor gene polymorphisms and primary biliary cirrhosis risk: a meta-analysis. Genet Mol Res. 2015;14(1):981\u20138.","journal-title":"Genet Mol Res"},{"issue":"7","key":"1248_CR12","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.dld.2018.12.022","volume":"51","author":"T Arai","year":"2019","unstructured":"Arai T, Atsukawa M, Tsubota A, Koeda M, Yoshida Y, Okubo T, et al. Association of vitamin D levels and vitamin D-related gene polymorphisms with liverfibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. Dig Liver Dis. 2019;51(7):1036\u201342.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"1248_CR13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/hep.22413","volume":"48","author":"N Muhanna","year":"2008","unstructured":"Muhanna N, Doron S, Wald O, Horani A, Eid A, Pappo O, Friedman SL, Safadi R. Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis. Hepatology. 2008;48(3):963\u20137.","journal-title":"Hepatology."},{"key":"1248_CR14","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1136\/gut.2010.234666","volume":"60","author":"S Abramovitch","year":"2011","unstructured":"Abramovitch S, Dahan-Bachar L, Sharvit E, Weisman Y, Ben Tov A, Brazowski E, Reif S. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut. 2011;60:1728\u201337.","journal-title":"Gut."},{"key":"1248_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","volume":"153","author":"N Ding","year":"2013","unstructured":"Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, et al. A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response. Cell. 2013;153:601\u201313.","journal-title":"Cell."}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01248-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-020-01248-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01248-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T23:14:12Z","timestamp":1618010052000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-020-01248-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,10]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1248"],"URL":"https:\/\/doi.org\/10.1186\/s12876-020-01248-5","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,10]]},"assertion":[{"value":"21 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal protocols were approved by the institutional animal care ethical committee of the Hebrew University and housed in a barrier facility under the ethic number: MD-18-154,943.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors indicated no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors indicated no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}